Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19

Articolo
Data di Pubblicazione:
2023
Citazione:
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 / Alfano, G.; Morisi, N.; Ferri, C.; Fontana, F.; Giovanella, S.; Ligabue, G.; Mori, G.; Franceschini, E.; Ferrari, A.; Gregorini, M.; Cappelli, G.; Tagliazucchi, S.; Pecorari, M.; Guaraldi, G.; Magistroni, R.; Donati, G.. - In: RENAL REPLACEMENT THERAPY. - ISSN 2059-1381. - 9:1(2023), pp. 35-43. [10.1186/s41100-023-00487-y]
Abstract:
Background: The weakened immune system of patients on hemodialysis (HD) may prolong SARS-CoV-2 infection compared to the general population. Current international guidelines recommend ending isolation in conjunction with serial testing in moderately and severely immunocompromised subjects. This study aimed to estimate SARS-CoV-2 infectivity by measuring RT-PCR test positivity in HD patients. A comparison between RT-PCR test and cycle threshold (Ct) value has been performed as a secondary endpoint. Methods: A single-center retrospective study was conducted at the University of Modena (Italy) from March 2020 to October 2022. Only patients on chronic HD therapy with COVID-19 were enrolled in the study. In our HD Center, two negative nasopharyngeal reverse transcription polymerase chain reaction (RT-PCR) results were used to end quarantine in this population. SARS-CoV-2 RT-PCR test positivity duration measured the time elapsed from a positive RT-PCR to a second negative test. Ct cut-off of 35 cycles was used to definite “high Ct value,” a condition characterized by a large number of cycles of PCR amplification to register a positive RT-PCR test. Results: During the observational period, 159 cases of SARS-CoV-2 infections were diagnosed in 151 patients. Median age was 70.1 (54.3–81.6) years and males accounted for 59.6% of the COVID-19 population. Median duration of SARS-CoV-2 RT-PCR test positivity on the nasal mucosa accounted for 30 (IQR, 21–40.5) days. Unvaccinated patients experienced significantly longer RT-PCR test positivity compared to vaccinated patients (42 [IQR,31–56] vs. 28 [IQR,20–35.7] days; p = < 0.001). The use of high Ct value, a laboratory surrogate of SARS-CoV-2 replication, anticipated a negative RT-PCR test of 9 (IQR, 6–12) days. Multivariate linear regression analysis showed that increased age (β coefficient 0.31; confidence interval [CI] 95%, 0.14—0.43; p = < 0.001) and the lack of anti-SARS-CoV-2 vaccination (β 0.49 CI95%, 11.9–22.5; p = < 0.001) were predictors of a prolonged RT-PCR positivity. Conclusions: Patients with COVID-19 on HD had prolonged RT-PCR test positivity. The adoption of “high Ct value” criteria led to a significant reduction in the duration of RT-PCR test positivity compared to the use of the classical nucleic acid amplification test. In our study, the lack of SARS-CoV-2 vaccination and older age were independently associated with a longer RT-PCR positivity.
Tipologia CRIS:
Articolo su rivista
Keywords:
COVID-19; Ct value; Hemodialysis; Hospitalization; Mortality; RT-PCR; SARS-COV-2; Vaccine; Virus hesitancy; Virus shedding
Elenco autori:
Alfano, G.; Morisi, N.; Ferri, C.; Fontana, F.; Giovanella, S.; Ligabue, G.; Mori, G.; Franceschini, E.; Ferrari, A.; Gregorini, M.; Cappelli, G.; Tagliazucchi, S.; Pecorari, M.; Guaraldi, G.; Magistroni, R.; Donati, G.
Autori di Ateneo:
Alfano Gaetano
Donati Gabriele
FRANCESCHINI Erica
GIOVANELLA SILVIA
GUARALDI Giovanni
LIGABUE Giulia
MAGISTRONI Riccardo
MORISI NICCOLO'
Link alla scheda completa:
https://iris.unimore.it/handle/11380/1312806
Link al Full Text:
https://iris.unimore.it//retrieve/handle/11380/1312806/582584/Alfano%20RRT%202023.pdf
Pubblicato in:
RENAL REPLACEMENT THERAPY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0